Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Exacctnt who wrote (1815)	5/3/1999 12:14:00 AM
From: Marshall Teitelbaum	Respond to of 2205

Bob, Thanks for posting it to the board. I saw it last week, and it generally gives some idea of the potential of off-the-shelf cartilage, vs the current carticel approach of GZTC, although carticel is already available. I would expect further news than just this, given the movement thus far. It is rumored by a generally reliable poster on Yahoo to not be associated with DG, which wouldn't be a surprise, given the distance away til completion still, even though we're now likely within 5ish months until FDA presentation, and within 12 weeks of completing the 180 person(with 12 week follow-up) study(interim analysis). There is a large orthopaedic meeting scheduled for wednesday, which may reveal some useful update regarding the cartilage research. Regards, and hope everyone's monday here is a good one. Marshall